Abstract
A significant increase in the myeloperoxidase (MPO) activity has been found in plasma of patients with stable angina and with acute coronary syndrome (ACS) in comparison with the control group. MPO concentration was significantly increased in plasma of ACS patients. Reduced MPO activity in the treated ACS patients correlated with a favorable outcome of the disease. Generally, changes in plasma MPO concentration coincided with changes in lactoferrin concentration thus confirming the role of neutrophil degranulation in the increase of plasma concentrations of these proteins. The increase in MPO activity was obviously determined by modification of the MPO protein caused by reactive oxygen species and halogen in the molar ratio of 1: 25 and 1: 50. The decrease in plasma MPO activity may be associated with increased plasma concentrations of the physiological inhibitor of its activity, ceruloplasmin, and also with modification of the MPO protein with reactive oxygen species and halogen at their molar ratio of 1: 100 and higher. Thus, MPO activity may be used for evaluation of effectiveness of the treatment of cardiovascular diseases.
Similar content being viewed by others
Abbreviations
- ACS:
-
acute coronary syndrome
- ELISA:
-
enzyme linked immunosorbent assay
- IHD:
-
ischemic heart disease
- MI:
-
myocardial infarction
- MPO:
-
myeloperoxidase
References
Schindhelm, R.K., van der Zwan, L.P., Teerlink, T., and Scheffer, P.G., Clinical Chemistry, 2009, vol. 55, pp. 1462–1470. doi 10.173/clinchem.2009.126029
Nicholls, S.J. and Hazen, S.L., Arteriosclerosis, Thrombosis, and Vascular Biology, 2005, vol. 25, pp. 1102–1111.
Samygina, V.R., Sokolov, A.V., Bourenkov, G., Petoukhov, M.V., Pulina, M.O., Zakharova, E.T., Vasilyev, V.B., Bartunik, H., and Svergun, D.I., PLoS One, 2013, vol. 8, p. e67145. doi 10.1371/journal.pone.0067145
Sokolov, A.V., Zakahrova, E.T., Kostevich, V.A., Samygina, V.R., and Vasilyev, V.B., Biometals, 2014, vol. 27, pp. 815–828. doi 10.1007/s10534-014-9755-2
Tang, W.H., Wu, Y., Hartiala, J., Fan, Y., Stewart, A.F., Roberts, R., McPherson, R., Fox, P.L., Allayee, H., and Hazen, S.L., Arteriosclerosis, Thrombosis, and Vascular Biology, 2012, vol. 32, no. 2, pp. 516–522. doi 10.1161/ATVBAHA.111.237040
Wu, A.H., Clinical Chemistry, 2009, vol. 55, no. 1, pp. 12–14. doi 10.1373/clinchem.2008.118208.
Zhang, R., Brennan, M.L., Fu, X., Aviles, R.J., Pearce, G.L., Penn, M.S., Topol, E.J., Sprecher, D.L., and Hazen, S.L., J. Amer. Med. Assoc., 2001, vol. 286, pp. 2136–2142.
Morrow, D.A., Sabatine, M.S., Brennan, M.-L., de Lemos, J., Murphy, S.A., Ruff, C.T., Cannon, C.P., and Hazen, S.L., European Heart J., 2008, vol. 29, no. 9, pp. 1096–1102.
Brennan, M.L., Penn, M.S., van Lente, F., Nambi, V., Shishehbor, M.H., Aviles, R.J., Goormastic, M., Pepoy, M.L., McErlean, E.S., Topol, E.J., Nissen, S.E., and Hazen, S.L., N. Engl. J. Med., 2003, vol. 349, pp. 1595–1604.
Zhang, R., Shen, Z., Nauseef, W.M., and Hazen, S.L., Blood, 2002, vol. 99, pp. 1802–1810.
Castellani, L.W., Chang, J.J., Wang, X., Lusis, A.J., and Reynolds, W.F., J. Lipid Res., 2006, vol. 47, pp. 1366–1377.
van der Veen, B.S., de Winther, M.P., and Heeringa, P., Antioxidants & Redox Signaling, 2009, vol. 11, pp. 2899–2939. doi 10.1089/ARS.2009.2538
Sokolov, A.V., Ageeva, K.V., Cherkalina, O.S., Pulina M.O., Zakharova, E.T., Prozorovskii, V.N., Aksenov, D.V., Vasilyev, V.B., and Panasenko, O.M., Chemistry and Physics of Lipids, 2010, vol. 163, nos. 4-5, pp. 347–355. doi 10.1016/j.chemphyslip. 2010.02.002
Sokolov, A.V., Kostevich, V.A., Kozlov, S.O., Donskyi, I.S., Vlasova, I.I., Rudenko, A.O., Zakharova, E.T., Vasilyev, V.B., and Panasenko, O.M. Free Radic. Res., 2015, vol. 49, pp. 777–789.
Gorudko, I.V., Cherkalina, O.S., Sokolov, A.V., Pulina,M.O., Zakharova, E.T., Vasilyev, V.B., Cherenkevich, S.N., and Panasenko, O.M., Bioorgan. Khim., 2009, vol. 35, pp. 629–639.
Ravin, H.A., J. Lab. Clin. Med., 1961, vol. 58, pp. 161–168.
Dominguez-Rodriguez, A. and Abreu-Gonzalez, P., Exp. Rev. Cardiovasc. Ther., 2011, vol. 9, no. 2, pp. 223–230. doi 10.1586/ERC.11.2
Sokolov, A.V., Kostevich, V.A., Zakharova, E.T., Samygina, V.R., Panasenko, O.M., and Vasilyev, V.B., Free Radical Res., 2015, vol. 49, no. 6, pp. 800–811. doi 10.3109/10715762.2015.1005615
Panasenko, O.M., Chekanov, A.V., Vlasova, I.I., Sokolov, A.V., Ageeva, K.V., Pulina, M.O., Cherkalina, O.S., and Vasilyev, V.B., Biofizika, 2008, vol. 53, pp. 573–581.
Sokolov, A.V., Ageeva, K.V., Pulina, M.O., Cherkalina, O.S., Samygina, V.R., Vlasova, I.I., Panasenko, O.M., Zakharova, E.T., and Vasilyev, V.B., Free Radical Res., 2008, vol. 42, nos. 11–12, pp. 989–998. doi 10.1080/10715760802566574
Panasenko, O.M., Gorudko, I.V., and Sokolov, A.V., Biochemistry (Moscow), 2013, vol. 78, pp. 1466–1489.
García-Montoya, I.A., Cendón, T.S., Arévalo-Gallegos, S., and Rascón-Cruz, Q., Biochim. Biophys. Acta, 2012, vol. 1820, pp. 226–236. doi 10.1016/j.bbagen.2011.06.018
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © D.V. Grigorieva, I.V. Gorudko, V.A. Kostevich, A.V. Sokolov, I.V. Buko, V.B. Vasilyev, L.Z. Polonetsky, O.M. Panasenko, S.N. Cherenkevich, 2016, published in Biomeditsinskaya Khimiya.
Rights and permissions
About this article
Cite this article
Grigorieva, D.V., Gorudko, I.V., Kostevich, V.A. et al. Plasma myeloperoxidase activity as a criterion of therapeutic effectiveness for patients with cardiovascular diseases. Biochem. Moscow Suppl. Ser. B 10, 173–179 (2016). https://doi.org/10.1134/S1990750816020050
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750816020050